FDA Inspection 604816 — GlaxoSmithKline Vaccines Srl
The FDA completed an inspection of GlaxoSmithKline Vaccines Srl on July 31, 2009 in Sovicille. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 31, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Sovicille (Italy)